Citations (248)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Dylan A. Hendy, Alex Haven, Eric M. Bachelder & Kristy M. Ainslie. (2023) Preclinical developments in the delivery of protein antigens for vaccination. Expert Opinion on Drug Delivery 20:3, pages 367-384.
Read now
Read now
Adam F. Sander & Pier-Luigi Lollini. (2018) Virus-like antigen display for cancer vaccine development, what is the potential?. Expert Review of Vaccines 17:4, pages 285-288.
Read now
Read now
Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Willem Adriaan de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni & Adam F. Sander. (2018) Virus-like particle display of HER2 induces potent anti-cancer responses. OncoImmunology 7:3.
Read now
Read now
Ludger Klimek, Carsten B. Schmidt-Weber, Matthias F. Kramer, Murray A. Skinner & Matthew D. Heath. (2017) Clinical use of adjuvants in allergen-immunotherapy. Expert Review of Clinical Immunology 13:6, pages 599-610.
Read now
Read now
Zenas Kuate Defo & Byong Lee. (2016) New approaches in oral rotavirus vaccines. Critical Reviews in Microbiology 42:3, pages 495-505.
Read now
Read now
Qun-ying Mao, Yiping Wang, Lianlian Bian, Miao Xu & Zhenglun Liang. (2016) EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Review of Vaccines 15:5, pages 599-606.
Read now
Read now
Vidadi Yusibov, Natasha Kushnir & Stephen J Streatfield. (2015) Advances and challenges in the development and production of effective plant-based influenza vaccines. Expert Review of Vaccines 14:4, pages 519-535.
Read now
Read now
Yoko Shoji, Alex Prokhnevsky, Brett Leffet, Nancy Vetter, Stephen Tottey, Shama Satinover, Konstantin Musiychuk, Moneim Shamloul, Joey Norikane, R Mark Jones, Jessica A Chichester, Brian J Green, Stephen J Streatfield & Vidadi Yusibov. (2015) Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana. Human Vaccines & Immunotherapeutics 11:1, pages 118-123.
Read now
Read now
Mitchell Tyler, Ebenezer Tumban & Bryce Chackerian. (2014) Second-generation prophylactic HPV vaccines: successes and challenges. Expert Review of Vaccines 13:2, pages 247-255.
Read now
Read now
Bertrand Bellier & David Klatzmann. (2013) Virus-like particle-based vaccines against hepatitis C virus infection. Expert Review of Vaccines 12:2, pages 143-154.
Read now
Read now
Fabiana Fernandes, Ana P Teixeira, Nuno Carinhas, Manuel JT Carrondo & Paula M Alves. (2013) Insect cells as a production platform of complex virus-like particles. Expert Review of Vaccines 12:2, pages 225-236.
Read now
Read now
Qiang Chen & Huafang Lai. (2013) Plant-derived virus-like particles as vaccines. Human Vaccines & Immunotherapeutics 9:1, pages 26-49.
Read now
Read now
Nicolas Cuburu & Bryce Chackerian. (2011) Genital delivery of virus-like particle and pseudovirus-based vaccines. Expert Review of Vaccines 10:9, pages 1245-1248.
Read now
Read now
Maja A Sommerfelt. (2009) Circular CCR5 peptide conjugates and uses thereof (WO2008074895). Expert Opinion on Therapeutic Patents 19:9, pages 1323-1328.
Read now
Read now
Yu-Chen Hu, Kun Yao & Tzong-Yuan Wu. (2008) Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Review of Vaccines 7:3, pages 363-371.
Read now
Read now
Gunther Spohn & Martin F Bachmann. (2008) Exploiting viral properties for the rational design of modern vaccines. Expert Review of Vaccines 7:1, pages 43-54.
Read now
Read now
Alison A McCormick & Kenneth E Palmer. (2008) Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Review of Vaccines 7:1, pages 33-41.
Read now
Read now
Articles from other publishers (231)
Renu Poria, Deepak Kala, Rupak Nagraik, Yashika Dhir, Sunny Dhir, Bharat Singh, Naveen Kumar Kaushik, Md Salik Noorani, Ankur Kaushal & Shagun Gupta. (2024) Vaccine development: Current trends and technologies. Life Sciences 336, pages 122331.
Crossref
Crossref
Zahra Rashidijahanabad, Sherif Ramadan, Nicholas A. O'Brien, Athar Nakisa, Shuyao Lang, Howard Crawford, Jeffrey C. Gildersleeve & Xuefei Huang. (2023)
Stereoselective Synthesis of Sialyl Lewis
a
Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine
. Angewandte Chemie International Edition 62:47.
Crossref
Crossref
Zahra Rashidijahanabad, Sherif Ramadan, Nicholas A. O'Brien, Athar Nakisa, Shuyao Lang, Howard Crawford, Jeffrey C. Gildersleeve & Xuefei Huang. (2023)
Stereoselective Synthesis of Sialyl Lewis
a
Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine
. Angewandte Chemie 135:47.
Crossref
Crossref
Fabian G. Martinez, Ryszard A. Zielke, Cyrielle E. Fougeroux, Lixin Li, Adam F. Sander & Aleksandra E. Sikora. (2023)
Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved
Neisseria gonorrhoeae
SliC antigen that blocks human lysozyme
. Infection and Immunity.
Crossref
Crossref
Alexandra Fowler, Koen K. A. Van Rompay, Maureen Sampson, Javier Leo, Jennifer K. Watanabe, Jodie L. Usachenko, Ramya Immareddy, Debbie M. Lovato, John T. Schiller, Alan T. Remaley & Bryce Chackerian. (2023) A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates. npj Vaccines 8:1.
Crossref
Crossref
Tao Zeng, Weijie Zang, Han Xiao, Yifan Jiang, Sang Lin, Min Wang, Shiqing Li, Liannishang Li, Chunsen Li, Chunhua Lu & Huanghao Yang. (2023) Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen Loading. ACS Nano.
Crossref
Crossref
Tosha Pandya, Prachi Joshi, Rudree Pathak & Shreeraj Shah. (2023) Nano-vaccination Strategies: Applications and Challenges for Intranasal
Immunization. Current Pharmaceutical Biotechnology 24:8, pages 946-969.
Crossref
Crossref
Yanan Sheng, Zhengjun Li, Xuan Lin, Yanyan Ma, Ying Ren, Zhiguo Su, Guanghui Ma & Songping Zhang. (2023) The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine. Vaccine 41:33, pages 4867-4878.
Crossref
Crossref
Tiana Loan Young, Kevin Chang Wang, Andrew James Varley & Bowen Li. (2023) Clinical delivery of circular RNA: Lessons learned from RNA drug development. Advanced Drug Delivery Reviews 197, pages 114826.
Crossref
Crossref
Nils Hillebrandt & Jürgen Hubbuch. (2023) Size-selective downstream processing of virus particles and non-enveloped virus-like particles. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, Abyson Joseph, Ruchir Rastogi, Nupur Mehrotra Arora & Prabuddha K. Kundu. (2023) Platforms, advances, and technical challenges in virus-like particles-based vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Fadoua El Battioui, Fatima El Malki & Said Barrijal. 2023. Oncogenic Viruses. Oncogenic Viruses
173
189
.
Sayoni Ray, Armando Puente, Nicole F. Steinmetz & Jonathan K. Pokorski. (2022) Recent advancements in single dose slow‐release devices for prophylactic vaccines. WIREs Nanomedicine and Nanobiotechnology 15:1.
Crossref
Crossref
Yao Miao, Tao Yang, Shuxu Yang, Mingying Yang & Chuanbin Mao. (2022) Protein nanoparticles directed cancer imaging and therapy. Nano Convergence 9:1.
Crossref
Crossref
John C. Kraft, Minh N. Pham, Laila Shehata, Mitch Brinkkemper, Seyhan Boyoglu-Barnum, Kaitlin R. Sprouse, Alexandra C. Walls, Suna Cheng, Mike Murphy, Deleah Pettie, Maggie Ahlrichs, Claire Sydeman, Max Johnson, Alyssa Blackstone, Daniel Ellis, Rashmi Ravichandran, Brooke Fiala, Samuel Wrenn, Marcos Miranda, Kwinten Sliepen, Philip J.M. Brouwer, Aleksandar Antanasijevic, David Veesler, Andrew B. Ward, Masaru Kanekiyo, Marion Pepper, Rogier W. Sanders & Neil P. King. (2022) Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens. Cell Reports Medicine 3:10, pages 100780.
Crossref
Crossref
Min Li, Zhihui Liang, Chen Chen, Ge Yu, Zhiying Yao, Yiyang Guo, Lei Zhang, Hang Bao, Duo Fu, Xuecheng Yang, Huiyang Wang, Changying Xue & Bingbing Sun. (2022) Virus-Like Particle-Templated Silica-Adjuvanted Nanovaccines with Enhanced Humoral and Cellular Immunity. ACS Nano 16:7, pages 10482-10495.
Crossref
Crossref
Yi-xue Sun, Zheng-rong Li, Peng-ju Zhang, Jin-hong Han, Hai-yang Di, Jia-yi Qin & Yan-long Cong. (2022) A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals. Frontiers in Immunology 13.
Crossref
Crossref
Cosette G. Schneider, Julien Fey, Xiaoyan Zou, Vince Gerbasi, Tatyana Savransky, Carl Batt, Elke Bergmann-Leitner & Evelina Angov. (2022) Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine 40:31, pages 4270-4280.
Crossref
Crossref
Alexandra Buckley & Kelly Lager. (2022) Senecavirus A: Frequently asked questions. Journal of Swine Health and Production 30:3, pages 149-159.
Crossref
Crossref
Iqra Mir, Sania Aamir, Syed Rizwan Hussain Shah, Muhammad Shahid, Iram Amin, Samia Afzal, Amjad Nawaz, Muhammad Umer Khan & Muhammad Idrees. (2022) Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic. Osong Public Health and Research Perspectives 13:2, pages 84-100.
Crossref
Crossref
Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Murali Muniraju, Esther Rodriguez & Javier Gordon Ogembo. (2022) Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Frontiers in Immunology 13.
Crossref
Crossref
Zhidong Teng, Fengping Hou, Manyuan Bai, Jiajun Li, Jun Wang, Jinen Wu, Jiaxi Ru, Mei Ren, Shiqi Sun & Huichen Guo. (2022) Bio-mineralization of virus-like particles by metal–organic framework nanoparticles enhances the thermostability and immune responses of the vaccines. Journal of Materials Chemistry B 10:15, pages 2853-2864.
Crossref
Crossref
Sayoni Ray, David M. Wirth, Oscar A. Ortega-Rivera, Nicole F. Steinmetz & Jonathan K. Pokorski. (2022) Dissolving Microneedle Delivery of a Prophylactic HPV Vaccine. Biomacromolecules 23:3, pages 903-912.
Crossref
Crossref
Farshad Hemmati, Mohsen Hemmati-Dinarvand, Marziye Karimzade, Daria Rutkowska, Mohammad Hadi Eskandari, Sayyad Khanizadeh & Alireza Afsharifar. (2021) Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2. Biotechnology Letters 44:1, pages 45-57.
Crossref
Crossref
Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo Kratje & Claudio Prieto. (2021) Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Applied Microbiology and Biotechnology 106:2, pages 579-592.
Crossref
Crossref
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Jhanvi Sharma, Carcia S. Carson, Trevor Douglas, John T. Wilson & Sebastian Joyce. 2022. Vaccine Design. Vaccine Design
367
398
.
Cheri Peyton Goodall, Benjamin Schwarz, Ekaterina Selivanovitch, John Avera, Joseph Wang, Heini Miettinen & Trevor Douglas. (2021) Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling. ACS Applied Bio Materials 4:12, pages 8205-8214.
Crossref
Crossref
Alejandro Hernández-Soto & Randall Chacón-Cerdas. (2021) RNAi Crop Protection Advances. International Journal of Molecular Sciences 22:22, pages 12148.
Crossref
Crossref
Nils Hillebrandt, Philipp Vormittag, Annabelle Dietrich, Christina H. Wegner & Jürgen Hubbuch. (2021) Process development for cross‐flow diafiltration‐based VLP disassembly: A novel high‐throughput screening approach. Biotechnology and Bioengineering 118:10, pages 3926-3940.
Crossref
Crossref
Kevin P. Dalton, Carmen Alvarado, Edel Reytor, Maria del Carmen Nuñez, Ana Podadera, Diego Martínez-Alonso, Jose Manuel Martin Alonso, Ines Nicieza, Silvia Gómez-Sebastián, Romy M. Dalton, Francisco Parra & José M. Escribano. (2021) Chimeric VLPs Bearing VP60 from Two Serotypes of Rabbit Haemorrhagic Disease Virus Are Protective against Both Viruses. Vaccines 9:9, pages 1005.
Crossref
Crossref
Muhammad Naveed Anwar, Chunying Jiang, Di Di, Junjie Zhang, Shuang Guo, Xin Wang, Muddassar Hameed, Abdul Wahaab, Donghua Shao, Zongjie Li, Ke Liu, Beibei Li, Yafeng Qiu, Zhiyong Ma & Jianchao Wei. (2021) A Novel Recombinant Virus-Like Particles Displaying B and T Cell Epitopes of Japanese Encephalitis Virus Offers Protective Immunity in Mice and Guinea Pigs. Vaccines 9:9, pages 980.
Crossref
Crossref
Marisa L. Martino, Stephen N. Crooke, Marianne Manchester & M.G. Finn. (2021) Single-Point Mutations in Qβ Virus-like Particles Change Binding to Cells. Biomacromolecules 22:8, pages 3332-3341.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Ze-Hui Liu, Hui-Ling Xu, Guang-Wei Han, Li-Na Tao, Ying Lu, Su-Ya Zheng, Wei-Huan Fang & Fang He. (2021) Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs. Frontiers in Immunology 12.
Crossref
Crossref
Ze-Hui Liu, Hui-Ling Xu, Guang-Wei Han, Li-Na Tao, Ying Lu, Su-Ya Zheng, Wei-Huan Fang & Fang He. (2021) A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates. International Journal of Biological Macromolecules 183, pages 2162-2173.
Crossref
Crossref
Manan Patel, Nirav Shah, Dhruvi Dave, Riddhi Trivedi, Keshava Jetha & Priyal Shah. (2021) A review on Effectivity of Plant based vaccines in the treatment of viral diseases. Journal of Drug Delivery and Therapeutics 11:3-S, pages 90-97.
Crossref
Crossref
Alexander Marin, Ananda Chowdhury, Sarah M. Valencia, Athina Zacharia, Reinhard Kirnbauer, Richard B.S. Roden, Ligia A. Pinto, Robert H. Shoemaker, Jason D. Marshall & Alexander K. Andrianov. (2021) Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine. Nanomedicine: Nanotechnology, Biology and Medicine 33, pages 102359.
Crossref
Crossref
Wagner Gouvêa dos Santos. (2021) Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines. Biomedicine & Pharmacotherapy 136, pages 111272.
Crossref
Crossref
Aline Maria Vasconcelos Queiroz, Johny Wysllas de Freitas Oliveira, Cláudia Jassica Moreno, Diego M. A. Guérin & Marcelo Sousa Silva. (2021) VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases. Vaccines 9:3, pages 220.
Crossref
Crossref
Maryam Moradi Vahdat, Farshad Hemmati, Abozar Ghorbani, Daria Rutkowska, Alireza Afsharifar, Mohammad Hadi Eskandari, Nahid Rezaei & Ali Niazi. (2021) Hepatitis B core-based virus-like particles: A platform for vaccine development in plants. Biotechnology Reports 29, pages e00605.
Crossref
Crossref
Lucie Jelínková, Hugo Jhun, Allison Eaton, Nikolai Petrovsky, Fidel Zavala & Bryce Chackerian. (2021) An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein. npj Vaccines 6:1.
Crossref
Crossref
Gayathri Chellasamy, Rose Mary Kiriyanthan, Saravanan Govindaraju, A. Radha & Kyusik Yun. 2021. Pandemic Outbreaks in the 21st Century. Pandemic Outbreaks in the 21st Century
235
243
.
Kalanghad P. Srinivas. 2021. Recent Developments in Applied Microbiology and Biochemistry. Recent Developments in Applied Microbiology and Biochemistry
3
12
.
Ki-Back Chu & Fu-Shi Quan. 2021. Nanoparticles for Rational Vaccine Design. Nanoparticles for Rational Vaccine Design
77
106
.
Alemu Tekewe Mogus, Lihong Liu, Manxue Jia, Diane T. Ajayi, Kai Xu, Rui Kong, Jing Huang, Jian Yu, Peter D. Kwong, John R. Mascola, David D. Ho, Moriya Tsuji & Bryce Chackerian. (2020) Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide. Vaccines 8:4, pages 765.
Crossref
Crossref
Xiangyu Liu, Yangkun Liu, Yuanyuan Zhang, Fan Zhang & Enqi Du. (2020) Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice. BMC Veterinary Research 16:1.
Crossref
Crossref
Arshak Poghossian, Melanie Jablonski, Denise Molinnus, Christina Wege & Michael J. Schöning. (2020) Field-Effect Sensors for Virus Detection: From Ebola to SARS-CoV-2 and Plant Viral Enhancers. Frontiers in Plant Science 11.
Crossref
Crossref
Laura M Stephens & Steven M Varga. (2020) Nanoparticle vaccines against respiratory syncytial virus. Future Virology 15:11, pages 763-778.
Crossref
Crossref
Tingting Ye, Zifu Zhong, Adolfo García‐Sastre, Michael Schotsaert & Bruno G. De Geest. (2020) Current Status of COVID‐19 (Pre)Clinical Vaccine Development. Angewandte Chemie International Edition 59:43, pages 18885-18897.
Crossref
Crossref
Tingting Ye, Zifu Zhong, Adolfo García‐Sastre, Michael Schotsaert & Bruno G. De Geest. (2020) Current Status of COVID‐19 (Pre)Clinical Vaccine Development. Angewandte Chemie 132:43, pages 19045-19057.
Crossref
Crossref
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang & Hinh Ly. (2020) Emerging Concepts and Technologies in Vaccine Development. Frontiers in Immunology 11.
Crossref
Crossref
David J. Pattinson, Simon H. Apte, Nani Wibowo, Tania Rivera-Hernandez, Penny L. Groves, Anton P. J. Middelberg & Denise L. Doolan. (2020) Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8+ T Cell Responses but Differ in Capacity to Induce CD4+ T Cell Responses and Antibody Responses. Frontiers in Immunology 11.
Crossref
Crossref
Tao Hua, Daohua Zhang, Bo Tang, Chen Chang, Guoyang Liu & Xuehua Zhang. (2020) The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus. Veterinary Microbiology 248, pages 108795.
Crossref
Crossref
Mei Ji, Jie Zhu, Xi-xiu Xie, Dong-qun Liu, Bin Wang, Zhuo Yu & Rui-tian Liu. (2020) A novel rapid modularized hepatitis B core virus-like particle-based platform for personalized cancer vaccine preparation via fixed-point coupling. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102223.
Crossref
Crossref
Jason A. Joyner, Seth M. Daly, Julianne Peabody, Kathleen D. Triplett, Srijana Pokhrel, Bradley O. Elmore, Diane Adebanjo, David S. Peabody, Bryce Chackerian & Pamela R. Hall. (2020) Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity. Toxins 12:7, pages 450.
Crossref
Crossref
Jesús Zepeda-Cervantes, Josué Orlando Ramírez-Jarquín & Luis Vaca. (2020) Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs. Frontiers in Immunology 11.
Crossref
Crossref
Mei Ji, Xi-xiu Xie, Dong-qun Liu, Shuai Lu, Ling-xiao Zhang, Ya-ru Huang & Rui-tian Liu. (2020) Engineered hepatitis B core virus-like particle carrier for precise and personalized Alzheimer’s disease vaccine preparation via fixed-point coupling. Applied Materials Today 19, pages 100575.
Crossref
Crossref
Sigridur Jonsdottir, Victoria Fettelschoss, Florian Olomski, Stephanie C. Talker, Jelena Mirkovitch, Tanya Rhiner, Katharina Birkmann, Franziska Thoms, Bettina Wagner, Martin F. Bachmann, Thomas M. Kündig, Eliane Marti & Antonia Fettelschoss-Gabriel. (2020) Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses. Vaccines 8:2, pages 213.
Crossref
Crossref
Philipp Vormittag, Thorsten Klamp & Jürgen Hubbuch. (2020) Ensembles of Hydrophobicity Scales as Potent Classifiers for Chimeric Virus-Like Particle Solubility – An Amino Acid Sequence-Based Machine Learning Approach. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Mattia Santoni, Roberta Zampieri & Linda Avesani. (2020) Plant Virus Nanoparticles for Vaccine Applications. Current Protein & Peptide Science 21:4, pages 344-356.
Crossref
Crossref
Feihu Yan, Entao Li, Ling Li, Zachary Schiffman, Pei Huang, Shengnan Zhang, Guohua Li, Hongli Jin, Hualei Wang, Xinghai Zhang, Yuwei Gao, Na Feng, Yongkun Zhao, Chengyu Wang & Xianzhu Xia. (2020) Virus-Like Particles Derived From a Virulent Strain of Pest des Petits Ruminants Virus Elicit a More Vigorous Immune Response in Mice and Small Ruminants Than Those From a Vaccine Strain. Frontiers in Microbiology 11.
Crossref
Crossref
Jhanvi Sharma, Kelly Shepardson, Laura L. Johns, Julia Wellham, John Avera, Benjamin Schwarz, Agnieszka Rynda-Apple & Trevor Douglas. (2020) A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability. ACS Applied Materials & Interfaces 12:16, pages 18211-18224.
Crossref
Crossref
Jiarong Zhou, Ashley V. Kroll, Maya Holay, Ronnie H. Fang & Liangfang Zhang. (2019) Biomimetic Nanotechnology toward Personalized Vaccines. Advanced Materials 32:13.
Crossref
Crossref
R. Sausset, M.A. Petit, V. Gaboriau-Routhiau & M. De Paepe. (2020) New insights into intestinal phages. Mucosal Immunology 13:2, pages 205-215.
Crossref
Crossref
Alex J. Spice, Rochelle Aw, Daniel G. Bracewell & Karen M. Polizzi. (2020) Synthesis and Assembly of Hepatitis B Virus-Like Particles in a Pichia pastoris Cell-Free System. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Yuetao Li, Li Han, Yongkun Zhao, Xuexing Zheng, Hualei Wang, Weiwei Gai, Hongli Jin, Guohua Li, Qi Wang, Na Feng, Yuwei Gao, Songtao Yang & Xianzhu Xia. (2020) Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice. Frontiers in Veterinary Science 7.
Crossref
Crossref
Kara-Lee Aves, Louise Goksøyr & Adam F. Sander. (2020) Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines. Viruses 12:2, pages 185.
Crossref
Crossref
Rosamund Chapman, Michiel van Diepen, Shireen Galant, Elizabeth Kruse, Emmanuel Margolin, Phindile Ximba, Tandile Hermanus, Penny Moore, Nicola Douglass, Anna-Lise Williamson & Edward Rybicki. (2020) Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles. Vaccines 8:1, pages 54.
Crossref
Crossref
Zhilin Chen, Wei-Yun Wholey, Alireza Hassani Najafabadi, James J. Moon, Irina Grigorova, Bryce Chackerian & Wei Cheng. (2020) Self-Antigens Displayed on Liposomal Nanoparticles above a Threshold of Epitope Density Elicit Class-Switched Autoreactive Antibodies Independent of T Cell Help. The Journal of Immunology 204:2, pages 335-347.
Crossref
Crossref
Jae-in Shin, Young Chan Park & Jae Min Song. (2020) Influence of temperature on the antigenic changes of virus-like particles. Clinical and Experimental Vaccine Research 9:2, pages 126.
Crossref
Crossref
Xiangpeng Chen, Yong Zhang, Naiying Mao, Shuangli Zhu, Tianjiao Ji & Wenbo Xu. (2019) Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice. Archives of Virology 164:12, pages 2975-2984.
Crossref
Crossref
Gunner P. Johnston, Birgit Bradel-Tretheway, Paul D. Piehowski, Heather M. Brewer, Bom Nae Rin Lee, Nicholas T. Usher, J. Lizbeth Reyes Zamora, Victoria Ortega, Erik M. Contreras, Jeremy R. Teuton, Jason P. Wendler, Keesha M. Matz, Joshua N. Adkins & Hector C. Aguilar. (2019) Nipah Virus-Like Particle Egress Is Modulated by Cytoskeletal and Vesicular Trafficking Pathways: a Validated Particle Proteomics Analysis. mSystems 4:5.
Crossref
Crossref
Yan, Banadyga, Zhao, Zhao, Schiffman, Huang, Li, Wang, Gao, Feng, Wang, Wang, Xia, Yang, Qiu & Wang. (2019) Peste des Petits Ruminants Virus-Like Particles Induce a Potent Humoral and Cellular Immune Response in Goats. Viruses 11:10, pages 918.
Crossref
Crossref
Franziska Thoms, Gary T. Jennings, Melanie Maudrich, Monique Vogel, Stefanie Haas, Andris Zeltins, Regina Hofmann-Lehmann, Barbara Riond, Jonas Grossmann, Peter Hunziker, Antonia Fettelschoss-Gabriel, Gabriela Senti, Thomas M. Kündig & Martin F. Bachmann. (2019) Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. Journal of Allergy and Clinical Immunology 144:1, pages 193-203.
Crossref
Crossref
David J. Pattinson, Simon H. Apte, Nani Wibowo, Yap P. Chuan, Tania Rivera-Hernandez, Penny L. Groves, Linda H. Lua, Anton P. J. Middelberg & Denise L. Doolan. (2019) Chimeric Murine Polyomavirus Virus-Like Particles Induce Plasmodium Antigen-Specific CD8+ T Cell and Antibody Responses. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Nicole M. Maphis, Julianne Peabody, Erin Crossey, Shanya Jiang, Fadi A. Jamaleddin Ahmad, Maria Alvarez, Soiba Khalid Mansoor, Amanda Yaney, Yirong Yang, Laurel O. Sillerud, Colin M. Wilson, Reed Selwyn, Jonathan L. Brigman, Judy L. Cannon, David S. Peabody, Bryce Chackerian & Kiran Bhaskar. (2019) Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy. npj Vaccines 4:1.
Crossref
Crossref
Renata G.F. Alvim, Ivaldo ItabaianaJrJr & Leda R. Castilho. (2019) Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform. Vaccine.
Crossref
Crossref
Manyuan Bai, Hu Dong, Xin Su, Ye Jin, Shiqi Sun, Yingpeng Zhang, Yunshang Yang & Huichen Guo. (2019) Hollow mesoporous silica nanoparticles as delivery vehicle of foot‐and‐mouth disease virus‐like particles induce persistent immune responses in guinea pigs. Journal of Medical Virology 91:6, pages 941-948.
Crossref
Crossref
Marieke E. Klijn, Philipp Vormittag, Nicolai Bluthardt & Jürgen Hubbuch. (2019) High-throughput computational pipeline for 3-D structure preparation and in silico protein surface property screening: A case study on HBcAg dimer structures. International Journal of Pharmaceutics 563, pages 337-346.
Crossref
Crossref
Daniel Hatlem, Thomas Trunk, Dirk Linke & Jack C. Leo. (2019) Catching a SPY: Using the SpyCatcher-SpyTag and Related Systems for Labeling and Localizing Bacterial Proteins. International Journal of Molecular Sciences 20:9, pages 2129.
Crossref
Crossref
Yuhua Xu, Shuzhi Ma, Yangbo Huang, Fengying Chen, Liyun Chen, Dong Ding, Yanping Zheng, Hua Li, Jing Xiao, Jin Feng & Tao Peng. (2019) Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells. Vaccine 37:17, pages 2340-2347.
Crossref
Crossref
Hayley K. Charlton Hume, João Vidigal, Manuel J. T. Carrondo, Anton P. J. Middelberg, António Roldão & Linda H. L. Lua. (2018) Synthetic biology for bioengineering virus‐like particle vaccines. Biotechnology and Bioengineering 116:4, pages 919-935.
Crossref
Crossref
Anne-Marie C. Andersson, Can M. Buldun, David J. Pattinson, Simon J. Draper & Mark Howarth. (2019) SnoopLigase peptide-peptide conjugation enables modular vaccine assembly. Scientific Reports 9:1.
Crossref
Crossref
Nastaran Taleghani, Ali Bozorg, Amin Azimi & Homa Zamani. (2019) Immunogenicity of HPV and HBV vaccines: adjuvanticity of synthetic analogs of monophosphoryl lipid A combined with aluminum hydroxide. APMIS 127:3, pages 150-157.
Crossref
Crossref
Sergio Rosales-Mendoza & Omar González-OrtegaSergio Rosales-Mendoza & Omar González-Ortega. 2019. Nanovaccines. Nanovaccines
319
336
.
Jens Schumacher, Tijana Bacic, René Staritzbichler, Matin Daneschdar, Thorsten Klamp, Philipp Arnold, Sabrina Jägle, Özlem Türeci, Jürgen Markl & Ugur Sahin. (2018) Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide. Journal of Nanobiotechnology 16:1.
Crossref
Crossref
Ludger Klimek, Thomas Kündig, Matthias F. Kramer, Sonja Guethoff, Erika Jensen-Jarolim, Carsten B. Schmidt-Weber, Oskar Palomares, Mona O. Mohsen, Thilo Jakob & Martin Bachmann. (2018) Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo Journal International 27:8, pages 245-255.
Crossref
Crossref
Ludger Klimek, Thomas Kündig, Matthias F. Kramer, Sonja Guethoff, Erika Jensen-Jarolim, Carsten B. Schmidt-Weber, Oscar Palomares, Mona O. Mohsen, Thilo Jakob & Martin Bachmann. (2018) Virus-like particles in der Prophylaxe und Immuntherapie allergischer Erkrankungen. Allergo Journal 27:8, pages 22-33.
Crossref
Crossref
Andrew G. Diamos & Hugh S. Mason. (2018) High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors. Protein Expression and Purification 151, pages 86-92.
Crossref
Crossref
Zhidong Teng, Shiqi Sun, Hao Chen, Jie Huang, Ping Du, Hu Dong, Xiaoyu Xu, Suyu Mu, Zhijun Zhang & Huichen Guo. (2018) Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine. Vaccine 36:45, pages 6752-6760.
Crossref
Crossref
Antonia Fettelschoss-Gabriel, Victoria Fettelschoss, Franziska Thoms, Christoph Giese, Michelle Daniel, Florian Olomski, Jivko Kamarachev, Katharina Birkmann, Maya Bühler, Martin Kummer, Andris Zeltins, Eliane Marti, Thomas M. Kündig & Martin F. Bachmann. (2018) Treating insect-bite hypersensitivity in horses with active vaccination against IL-5. Journal of Allergy and Clinical Immunology 142:4, pages 1194-1205.e3.
Crossref
Crossref
Ki-Hye Kim, Young-Man Kwon, Young-Tae Lee, Min-Chul Kim, Hye Hwang, Eun-Ju Ko, Youri Lee, Hyo-Jick Choi & Sang-Moo Kang. (2018) Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus. Vaccines 6:4, pages 66.
Crossref
Crossref
Yangjie Wei, Prashant Kumar, Newton Wahome, Nicholas J. Mantis & C. Russell Middaugh. (2018) Biomedical Applications of Lumazine Synthase. Journal of Pharmaceutical Sciences 107:9, pages 2283-2296.
Crossref
Crossref
Helba Bredell, Jacques J. Smith, Johann F. Görgens & Willem H. van Zyl. (2018)
Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in
Pichia pastoris
and
Hansenula polymorpha
. Yeast 35:9, pages 519-529.
Crossref
Crossref
Guoqiang Wang, Yunchao Liu, Hua Feng, Yumei Chen, Suzhen Yang, Qiang Wei, Juan Wang, Dongmin Liu & Gaiping Zhang. (2018) Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus. PeerJ 6, pages e4823.
Crossref
Crossref
Hiep Khong, Annika Volmari, Meenu Sharma, Zhimin Dai, Chinonye S. Imo, Yared Hailemichael, Manisha Singh, Derek T. Moore, Zhilan Xiao, Xue-fei Huang, Thomas D. Horvath, David H. Hawke & Willem W. Overwijk. (2018) Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response. The Journal of Immunology 200:10, pages 3464-3474.
Crossref
Crossref
Yi Zhao, Xiaotian Zhao, Yuan Cheng, Xiaoshuang Guo & Weien Yuan. (2018) Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment. Molecular Pharmaceutics 15:5, pages 1791-1799.
Crossref
Crossref
Sanhua Wei, Yingfeng Lei, Jie Yang, Xiaoyan Wang, Fang Shu, Xin Wei, Fang Lin, Bin Li, Ying Cui, Hai Zhang & Sanhua Wei. (2018) Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes. Vaccine 36:17, pages 2273-2281.
Crossref
Crossref
Qiang Chen, Matthew Dent & Hugh Mason. 2018. Molecular Pharming. Molecular Pharming
231
273
.
Shilpa Ray & Mrutyunjay Suar. 2018. Biomedical Engineering. Biomedical Engineering
1353
1401
.
Xiaoli Wang, Zhiqiang Ku, Xiang Zhang, Xiaohua Ye, Jinhuan Chen, Qingwei Liu, Wei Zhang, Chao Zhang, Zhenglin Fu, Xia Jin, Yao Cong & Zhong Huang. (2018) Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid. Journal of Virology 92:1.
Crossref
Crossref
Bongseo Choi, Hansol Kim, Hyukjun Choi & Sebyung Kang. 2018. Biomimetic Medical Materials. Biomimetic Medical Materials
27
43
.
Gloria Spagnoli, Somayeh Pouyanfard, Davide Cavazzini, Elena Canali, Stefano Maggi, Massimo Tommasino, Angelo Bolchi, Martin Müller & Simone Ottonello. (2017) Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles. Scientific Reports 7:1.
Crossref
Crossref
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Joseph Torresi, Eric J. Gowans & Branka Grubor-Bauk. (2017) Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C. Frontiers in Microbiology 8.
Crossref
Crossref
Akane Urakami, Mya Myat Ngwe Tun, Meng Ling Moi, Atsuko Sakurai, Momoko Ishikawa, Sachiko Kuno, Ryuji Ueno, Kouichi Morita & Wataru Akahata. (2017) An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. Journal of Virology 91:23.
Crossref
Crossref
Fabien Pitoiset, Thomas Vazquez, Beatrice Levacher, Djamel Nehar-Belaid, Nicolas Dérian, James Vigneron, David Klatzmann & Bertrand Bellier. (2017) Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation. Journal of Virology 91:21.
Crossref
Crossref
Pramila Walpita, Yu Cong, Peter B. Jahrling, Oscar Rojas, Elena Postnikova, Shuiqing Yu, Lisa Johns & Michael. R. Holbrook. (2017) A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. npj Vaccines 2:1.
Crossref
Crossref
Hayley K. Charlton Hume & Linda H.L. Lua. (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35:35, pages 4480-4485.
Crossref
Crossref
Akane Urakami, Atsuko Sakurai, Momoko Ishikawa, Moh Lan Yap, Yevel Flores-Garcia, Yasunari Haseda, Taiki Aoshi, Fidel P. Zavala, Michael G. Rossmann, Sachiko Kuno, Ryuji Ueno & Wataru Akahata. (2017) Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus. Clinical and Vaccine Immunology 24:7.
Crossref
Crossref
Susheel K. Singh, Susan Thrane, Christoph M. Janitzek, Morten A. Nielsen, Thor G. Theander, Michael Theisen, Ali Salanti & Adam F. Sander. (2017) Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. Vaccine 35:30, pages 3726-3732.
Crossref
Crossref
Karl D. Brune, Can M. Buldun, Yuanyuan Li, Iona J. Taylor, Florian Brod, Sumi Biswas & Mark Howarth. (2017) Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization. Bioconjugate Chemistry 28:5, pages 1544-1551.
Crossref
Crossref
Seth M. Daly, Jason A. Joyner, Kathleen D. Triplett, Bradley O. Elmore, Srijana Pokhrel, Kathryn M. Frietze, David S. Peabody, Bryce Chackerian & Pamela R. Hall. (2017) VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation. Scientific Reports 7:1.
Crossref
Crossref
B. Schwarz, M. Uchida & T. Douglas. 2017.
1
60
.
M.F. Bachmann & M. Vogel. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
421
444
.
Benjamin Schwarz, Kaitlyn M. Morabito, Tracy J. Ruckwardt, Dustin P. Patterson, John Avera, Heini M. Miettinen, Barney S. Graham & Trevor Douglas. (2016) Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses. ACS Biomaterials Science & Engineering 2:12, pages 2324-2332.
Crossref
Crossref
Yingjun Li, Xiaoping Yi, Yingping Zhuang & Ju Chu. (2016) Regulation of porcine circovirus type 2-like particles expressed in baculovirus expression system. Bioresources and Bioprocessing 3:1.
Crossref
Crossref
Junfeng Xie, Kunpeng Li, Yuanzhu Gao, Runqing Huang, Yuxiong Lai, Yan Shi, Shaowei Yang, Guohua Zhu, Qinfen Zhang & Jianguo He. (2016) Structural analysis and insertion study reveal the ideal sites for surface displaying foreign peptides on a betanodavirus-like particle. Veterinary Research 47:1.
Crossref
Crossref
Susan Thrane, Christoph M. Janitzek, Sungwa Matondo, Mafalda Resende, Tobias Gustavsson, Willem Adriaan de Jongh, Stine Clemmensen, Will Roeffen, Marga van de Vegte‑Bolmer, Geert Jan van Gemert, Robert Sauerwein, John T. Schiller, Morten A. Nielsen, Thor G. Theander, Ali Salanti & Adam F. Sander. (2016) Bacterial superglue enables easy development of efficient virus-like particle based vaccines. Journal of Nanobiotechnology 14:1.
Crossref
Crossref
Christopher P. Karch & Peter Burkhard. (2016) Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochemical Pharmacology 120, pages 1-14.
Crossref
Crossref
Yu Zhou, Chaoyun Shen, Chao Zhang, Wei Zhang, Lili Wang, Ke Lan, Qingwei Liu & Zhong Huang. (2016) Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice. Antiviral Research 132, pages 165-169.
Crossref
Crossref
Huimin Guo, Jie Zhu, Yonggui Tan, Chuanfeng Li, Zongyan Chen, Shiqi Sun & Guangqing Liu. (2016) Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits. Antiviral Research 131, pages 85-91.
Crossref
Crossref
Karin L. Lee, Richard M. Twyman, Steven Fiering & Nicole F. Steinmetz. (2016) Virus‐based nanoparticles as platform technologies for modern vaccines. WIREs Nanomedicine and Nanobiotechnology 8:4, pages 554-578.
Crossref
Crossref
Ryohei Saga, Akira Fujimoto, Noriyuki Watanabe, Mami Matsuda, Makoto Hasegawa, Koichi Watashi, Hideki Aizaki, Noriko Nakamura, Shigeru Tajima, Tomohiko Takasaki, Eiji Konishi, Takanobu Kato, Michinori Kohara, Haruko Takeyama, Takaji Wakita & Ryosuke Suzuki. (2016) Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus. Scientific Reports 6:1.
Crossref
Crossref
Basavaraj Binjawadagi, Yashavanth Shaan Lakshmanappa, Zhu Longchao, Santosh Dhakal, Jagadish Hiremath, Kang Ouyang, Duan-Liang Shyu, Jesus Arcos, Shang Pengcheng, Aaron Gilbertie, Federico Zuckermann, Jordi B. Torrelles, Daral Jackwood, Ying Fang & Gourapura J. Renukaradhya. (2016) Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs. Archives of Virology 161:6, pages 1579-1589.
Crossref
Crossref
Yong-Dae Gwon, Sehyun Kim, Yeondong Cho, Yoonki Heo, Hansam Cho, Kihoon Park, Hee-Jung Lee, Jiwon Choi, Haryoung Poo & Young Bong Kim. (2016) Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1. PLOS ONE 11:5, pages e0154824.
Crossref
Crossref
Claudia Koch, Fabian J Eber, Carlos Azucena, Alexander Förste, Stefan Walheim, Thomas Schimmel, Alexander M Bittner, Holger Jeske, Hartmut Gliemann, Sabine Eiben, Fania C Geiger & Christina Wege. (2016) Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies. Beilstein Journal of Nanotechnology 7, pages 613-629.
Crossref
Crossref
T. V. Gasanova, N. V. Petukhova & P. A. Ivanov. (2016) Chimeric particles of tobacco mosaic virus as a platform for the development of next-generation nanovaccines. Nanotechnologies in Russia 11:3-4, pages 227-236.
Crossref
Crossref
Hyunil Kim, Yoo-kyoung Lee, Sang Chul Kang, Beom Ku Han & Ki Myung Choi. (2016) Recent vaccine technology in industrial animals. Clinical and Experimental Vaccine Research 5:1, pages 12.
Crossref
Crossref
Paul Pumpens, Regina Renhofa, Andris Dishlers, Tatjana Kozlovska, Velta Ose, Peter Pushko, Kaspars Tars, Elmars Grens & Martin F. Bachmann. (2016) The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology 59:2, pages 74-110.
Crossref
Crossref
Qunxing Pan, Hui Wang, Wei Ouyang, Xiaoli Wang, Zhenwei Bi, Xingxia Xia, Yongshan Wang & Kongwang He. (2016) Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease. Vaccine 34:4, pages 578-585.
Crossref
Crossref
Newton Wahome, John M. Hickey, David B. Volkin & C. Russell Middaugh. 2016. Vaccine Design. Vaccine Design
393
421
.
Claudia Koch, Katrin Wabbel, Fabian J. Eber, Peter Krolla-Sidenstein, Carlos Azucena, Hartmut Gliemann, Sabine Eiben, Fania Geiger & Christina Wege. (2015) Modified TMV Particles as Beneficial Scaffolds to Present Sensor Enzymes. Frontiers in Plant Science 6.
Crossref
Crossref
Javier Gordon Ogembo, Matthew R Muraswki, Lori W McGinnes, Agapi Parcharidou, Rujapak Sutiwisesak, Timelia Tison, Juan Avendano, Deep Agnani, Robert W Finberg, Trudy G Morrison & Joyce D Fingeroth. (2015) A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. Journal of Translational Medicine 13:1.
Crossref
Crossref
Azam Bolhassani, Zeinab Shirbaghaee, Elnaz Agi & Noushin Davoudi. (2015) VLP production in Leishmania tarentolae : A novel expression system for purification and assembly of HPV16 L1. Protein Expression and Purification 116, pages 7-11.
Crossref
Crossref
Dan Yan, Yan-Quan Wei, Hui-Chen Guo & Shi-Qi Sun. (2015) The application of virus-like particles as vaccines and biological vehicles. Applied Microbiology and Biotechnology 99:24, pages 10415-10432.
Crossref
Crossref
Susan Thrane, Christoph M. Janitzek, Mette Ø. Agerbæk, Sisse B. Ditlev, Mafalda Resende, Morten A. Nielsen, Thor G. Theander, Ali Salanti & Adam F. Sander. (2015) A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA. PLOS ONE 10:11, pages e0143071.
Crossref
Crossref
Jerri Caldeira, Jeremiah Bustos, Julianne Peabody, Bryce Chackerian & David S. Peabody. (2015) Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform. PLOS ONE 10:10, pages e0141407.
Crossref
Crossref
Lav Tripathi, Shailendra Mani, Rajendra Raut, Ankur Poddar, Poornima Tyagi, Upasana Arora, Aravinda de Silva, Sathyamangalam Swaminathan & Navin Khanna. (2015) Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies. Frontiers in Microbiology 6.
Crossref
Crossref
Benjamin Schwarz, Patrick Madden, John Avera, Bridget Gordon, Kyle Larson, Heini M. Miettinen, Masaki Uchida, Ben LaFrance, Gautam Basu, Agnieszka Rynda-Apple & Trevor Douglas. (2015) Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein. ACS Nano 9:9, pages 9134-9147.
Crossref
Crossref
Yanli Yang, Mengran Yu, Songping Zhang, Guanghui Ma & Zhiguo Su. (2015) Adsorption of virus-like particles on ion exchange surface: Conformational changes at different pH detected by dual polarization interferometry. Journal of Chromatography A 1408, pages 161-168.
Crossref
Crossref
Pramila Walpita, Lisa M. Johns, Ravi Tandon & Martin L. Moore. (2015) Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract. PLOS ONE 10:7, pages e0130755.
Crossref
Crossref
Chao Zhang, Zhiqiang Ku, Qingwei Liu, Xiaoli Wang, Tan Chen, Xiaohua Ye, Dapeng Li, Xia Jin & Zhong Huang. (2015) High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 33:20, pages 2335-2341.
Crossref
Crossref
Piergiuseppe Nestola, Cristina Peixoto, Ricardo R. J. S Silva, Paula M. Alves, José P. B. Mota & Manuel J. T. Carrondo. (2015) Improved virus purification processes for vaccines and gene therapy. Biotechnology and Bioengineering 112:5, pages 843-857.
Crossref
Crossref
Gorben P. Pijlman. (2015) Enveloped virus‐like particles as vaccines against pathogenic arboviruses. Biotechnology Journal 10:5, pages 659-670.
Crossref
Crossref
John P O’Rourke, David S Peabody & Bryce Chackerian. (2015) Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform. Current Opinion in Virology 11, pages 76-82.
Crossref
Crossref
Kiran Dallenbach, Patrik Maurer, Till Röhn, Franziska Zabel, Manfred Kopf & Martin F. Bachmann. (2015) Protective effect of a germline, IL‐17‐neutralizing antibody in murine models of autoimmune inflammatory disease. European Journal of Immunology 45:4, pages 1238-1247.
Crossref
Crossref
Elena Pascual, Carlos P. Mata, Josué Gómez-Blanco, Noelia Moreno, Juan Bárcena, Esther Blanco, Ariel Rodríguez-Frandsen, Amelia Nieto, José L. Carrascosa & José R. Castón. (2015) Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity. Journal of Virology 89:5, pages 2563-2574.
Crossref
Crossref
Shilpa Ray & Mrutyunjay Suar. 2015. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering
221
268
.
Zabihollah Shoja, Maria Tagliamonte, Somayeh Jalilvand, Yaghoub Mollaei-Kandelous, Angelo De stradis, Maria Lina Tornesello, Franco M. Buonaguro & Luigi Buonaguro. (2015) Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines. Journal of Medical Virology 87:1, pages 102-111.
Crossref
Crossref
Jaime Tomé-Amat, Lauren Fleischer, Stephanie A Parker, Cameron L Bardliving & Carl A Batt. (2014) Secreted production of assembled Norovirus virus-like particles from Pichia pastoris. Microbial Cell Factories 13:1.
Crossref
Crossref
Mitchell Tyler, Ebenezer Tumban, David S. Peabody & Bryce Chackerian. (2014) The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine. Biotechnology and Bioengineering 111:12, pages 2398-2406.
Crossref
Crossref
John P. O’Rourke, Seth M. Daly, Kathleen D. Triplett, David Peabody, Bryce Chackerian & Pamela R. Hall. (2014) Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway. PLoS ONE 9:11, pages e111198.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarBernd Kalbfuss‐Zimmermann & Udo Reichl. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
97
180
.
Emily P. Wen, Ronald Ellis & Narahari S. PujarShailaja Rabindran & Vidadi Yusibov. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
81
95
.
Christopher M. Capuano, Peter Grzesik, Dale Kreitler, Erin N. Pryce, Keshal V. Desai, Gavin Coombs, J. Michael McCaffery & Prashant J. Desai. (2014) A hydrophobic domain within the small capsid protein of Kaposi’s sarcoma-associated herpesvirus is required for assembly. Journal of General Virology 95:8, pages 1755-1769.
Crossref
Crossref
Mitchell Tyler, Ebenezer Tumban, Agnieszka Dziduszko, Michelle A. Ozbun, David S. Peabody & Bryce Chackerian. (2014) Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing. Vaccine 32:34, pages 4267-4274.
Crossref
Crossref
Zhiqiang Ku, Qingwei Liu, Xiaohua Ye, Yicun Cai, Xiaoli Wang, Jinping Shi, Dapeng Li, Xia Jin, Wenqi An & Zhong Huang. (2014) A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 32:34, pages 4296-4303.
Crossref
Crossref
Zhong-Hua Deng, Ye-Xia Hao, Li-Hong Yao, Zhi-Ping Xie, Han-Chun Gao, Le-Yun Xie, Li-li Zhong, Bing Zhang, You-De Cao & Zhao-Jun Duan. (2014) Immunogenicity of recombinant human bocavirus-1,2 VP2 gene virus-like particles in mice. Immunology 142:1, pages 58-66.
Crossref
Crossref
Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo & Anton P.J. Middelberg. (2014) Bioengineering virus-like particles as vaccines. Biotechnology and Bioengineering 111:3, pages 425-440.
Crossref
Crossref
Sabrina E. Vinzón, Ilona Braspenning-Wesch, Martin Müller, Edward K. Geissler, Ingo Nindl, Hermann-Josef Gröne, Kai Schäfer & Frank Rösl. (2014) Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model. PLoS Pathogens 10:2, pages e1003924.
Crossref
Crossref
Franco M Buonaguro & Luigi BuonaguroFabiana FernandesAna P TeixeiraNuno CarinhasManuel JT CarrondoPaula M Alves. 2014. Virus-like Particles in Vaccine Development. Virus-like Particles in Vaccine Development
120
134
.
Deqiang Wei, Xia Zhao, Limin Chen, Xingguo Lan, Yuhua Li, Yuan Lin & Qian Wang. (2014) Viral nanoparticles as antigen carriers: influence of shape on humoral immune responses in vivo. RSC Adv. 4:44, pages 23017-23021.
Crossref
Crossref
Arun K. Dhar, Sanjib K. Manna & F. C. Thomas Allnutt. (2013) Viral vaccines for farmed finfish. VirusDisease 25:1, pages 1-17.
Crossref
Crossref
Stephen J. Streatfield, Natasha Kushnir & Vidadi Yusibov. 2014. Commercial Plant-Produced Recombinant Protein Products. Commercial Plant-Produced Recombinant Protein Products
103
133
.
Niyati Khetarpal, Ankur Poddar, Satish K Nemani, Nisha Dhar, Aravind Patil, Priyanka Negi, Ashiya Perween, Ramaswamy Viswanathan, Heinrich Lünsdorf, Poornima Tyagi, Rajendra Raut, Upasana Arora, Swatantra K Jain, Ursula Rinas, Sathyamangalam Swaminathan & Navin Khanna. (2013) Dengue-specific subviral nanoparticles: design, creation and characterization. Journal of Nanobiotechnology 11:1.
Crossref
Crossref
Naoki Tomo, Toshiyuki Goto & Yuko Morikawa. (2013) Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae. Microbial Cell Factories 12:1.
Crossref
Crossref
Elisa Crisci, Juan Bárcena & María Montoya. (2013) Virus-like particle-based vaccines for animal viral infections. Inmunología 32:3, pages 102-116.
Crossref
Crossref
Fuxiao Liu, Xiaodong Wu, Lin Li, Shengqiang Ge, Zengshan Liu & Zhiliang Wang. (2013) Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design. Comparative Immunology, Microbiology and Infectious Diseases 36:4, pages 343-352.
Crossref
Crossref
Shailendra Mani, Lav Tripathi, Rajendra Raut, Poornima Tyagi, Upasana Arora, Tarani Barman, Ruchi Sood, Alka Galav, Wahala Wahala, Aravinda de Silva, Sathyamangalam Swaminathan & Navin Khanna. (2013) Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies. PLoS ONE 8:5, pages e64595.
Crossref
Crossref
Geraldine LescailleFabien PitoisetRodney MacedoClaude BaillouChristophe HuretDavid KlatzmannEric TartourFrançois M. LemoineBertrand Bellier. (2013) Efficacy of DNA Vaccines Forming E7 Recombinant Retroviral Virus-Like Particles for the Treatment of Human Papillomavirus-Induced Cancers. Human Gene Therapy 24:5, pages 533-544.
Crossref
Crossref
Jessica M. Moffat, Wan-Shoo Cheong, José A. Villadangos, Justine D. Mintern & Hans J. Netter. (2013) Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells. Vaccine 31:18, pages 2310-2316.
Crossref
Crossref
Kae Pusic, Zoraida Aguilar, Jaclyn McLoughlin, Sophie Kobuch, Hong Xu, Mazie Tsang, Andrew Wang & George Hui. (2012) Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood‐stage human malaria vaccine. The FASEB Journal 27:3, pages 1153-1166.
Crossref
Crossref
Erlinda Fernández, Jorge R. Toledo, Lídice Méndez, Nemecio González, Francisco Parra, José M. Martín-Alonso, Miladys Limonta, Kosara Sánchez, Ania Cabrales, Mario P. Estrada, Alina Rodríguez-Mallón & Omar Farnós. (2013) Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine. PLoS ONE 8:2, pages e56417.
Crossref
Crossref
Subhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, Warner K. Huh, Vijayarangam Damotharan, Sudha V. Chivukula & Richard B. S. Roden. (2013) Optimization of Multimeric Human Papillomavirus L2 Vaccines. PLoS ONE 8:1, pages e55538.
Crossref
Crossref
Peter Pushko, Paul Pumpens & Elmars Grens. (2013) Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures. Intervirology 56:3, pages 141-165.
Crossref
Crossref
Upasana Arora, Poornima Tyagi, Sathyamangalam Swaminathan & Navin Khanna. (2013) Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 31:6, pages 873-878.
Crossref
Crossref
Juan Bárcena & Esther Blanco. 2013. Structure and Physics of Viruses. Structure and Physics of Viruses
631
665
.
Qiang Chen. 2013. Molecular Vaccines. Molecular Vaccines
153
181
.
Sathyamangalam Swaminathan & Navin Khanna. 2013. Molecular Vaccines. Molecular Vaccines
135
151
.
Amit K. Goyal, Goutam Rath & Tarun Garg. 2013. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
67
120
.
Amit K. Goyal, Goutam Rath & Tarun Garg. 2013. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
67
120
.
Wu Ou, Josie Delisle, Jerome Jacques, Joanna Shih, Graeme Price, Jens H Kuhn, Vivian Wang, Daniela Verthelyi, Gerardo Kaplan & Carolyn A Wilson. (2012) Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain. Virology Journal 9:1.
Crossref
Crossref
Displaying 200 of 248 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list